Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Adolescent Care and Managing Biologic Therapy: Monitoring Guidelines for Immunomodulatory Drug Therapy
Description
The talk focuses on managing adolescent care and biologic therapy, particularly in the transition from pediatric to adult care. It emphasizes collaboration between primary care and dermatology providers to optimize patient well-being, especially as adolescents often face unique health challenges during this developmental stage. Key points include the importance of shared decision-making in treatment plans, regular monitoring of patient health, and coordinating vaccination efforts among care teams. The speaker underscores the complexities of handling biologic therapies, sharing insights on documentation and care structures that support both clinicians and patients. Using two illustrative case studies, the speaker showcases the need for a tailored approach in managing chronic conditions like hidradenitis suppurativa and severe eczema, noting the impact of psychosocial factors on treatment adherence. Additionally, the discussion touches on the importance of addressing vaccination needs for patients on biologics, with recommendations for flu, COVID-19, and meningococcal vaccines. Overall, the session advocates for a more integrated healthcare framework to address the evolving needs of adolescents receiving biologic treatments.
View moreConclusions
- Collaboration between primary care and dermatology providers is essential for transitioning adolescent patients on biologics to adult care.
- Standardized approaches for ongoing monitoring of adolescents on biologics need to be incorporated into shared decision-making.
- Best practices for vaccination coordination must involve joint efforts from primary care and dermatology teams.
- Empowering adolescents to manage their health is crucial in supporting their transition to adulthood, stressing the need for self-management and accountability.
- Healthcare systems must adapt to the unique challenges faced by adolescents with chronic conditions as they transition to adulthood.
- Addressing insurance coverage and medication approval disparities is critical during the transition from pediatric to adult healthcare.
- Patients on biologics require comprehensive education about their medications, including potential side effects, the importance of vaccination, and monitoring protocols.
- Personalized care strategies should consider individual patient complexities, such as mental health challenges and lifestyle factors that may affect treatment adherence.
- Fair Housing for Our Future, Laws & Litigation Conference 2022.
- White and Cooley, 2018 Oct 22
- Lee et al, Dermatological Reviews 2022
- Toledo et al, JAAD Int 2022
- Lorry G. Rubin M, Myron J. Levin, Per Ljungman, E. Graham Davies, Robin Avery, Marcie Tomblyn, Athos Bousvaros, Shireesha Dhanireddy, Lillian Sung, Harry Keyserling, Insoo Kang; A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology; Ann Allergy Asthma Immunol. 2024 Sep;133(3):286-294. doi: 10.1016/j.anai.2024.05.014. Epub 2024 Jun 5.